Bloomberg Law
Free Newsletter Sign Up
Login
BROWSE
Bloomberg Law
Welcome
Login
Advanced Search Go
Free Newsletter Sign Up

Lawmakers Urge HHS to Act to Cut Price of Astellas Drug Xtandi

April 1, 2016, 4:00 AM

Lawmakers are urging the HHS to exercise its rights to license generic versions of Astellas Pharma Inc.'s prostate cancer drug Xtandi as part of an effort to reduce the drug’s price.

A group of Senate and House lawmakers led by Reps. Lloyd Doggett (D-Texas) and Peter Welch (D-Vt.), co-chairs of the Prescription Drug Taskforce, as well as Sen. Bernie Sanders (I-Vt.), March 28 sent a letter to the Health and Human Services Department and the National Institutes of Health asking that the NIH hold a public hearing to consider using its march-in rights under the Bayh-Dole Act, 35 U.S.C. §203. ...